Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma

Glioblastoma is an incurable cancer with a 5-year survival chance of less than 5%. Chemotherapy is a therapeutic approach to treating the disease; however, due to the presence of the blood–brain barrier (BBB), the probability of success is low. To overcome this issue, nanoparticles are promising car...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaferi, Mohsen, Raza, Aun, Koohi, Maedeh, Zahra, Warda, Akbarzadeh, Azim, Ebrahimi Shahmabadi, Hasan, Alavi, Seyed Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609487/
https://www.ncbi.nlm.nih.gov/pubmed/36297618
http://dx.doi.org/10.3390/pharmaceutics14102183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609487/
https://www.ncbi.nlm.nih.gov/pubmed/36297618
http://dx.doi.org/10.3390/pharmaceutics14102183

Ejemplares similares